The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
Open accessAbstract
In the present study we demonstrate that human monocytes activated by lipopolysaccharides (LPS) were able to produce high levels of interleukin 10 (IL-10), previously designated cytokine synthesis inhibitory factor (CSIF), in a dose dependent fashion. IL-10 was detectable 7 h after activation of the monocytes and maximal levels of IL-10 production were observed after 24-48 h. These kinetics indicated that the production of IL-10 by human monocytes was relatively late as compared to the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, tumor necrosis factor alpha (TNF alpha), and granulocyte colony-stimulating factor (G-CSF), which were all secreted at high levels 4-8 h after activation. The production of IL-10 by LPS activated monocytes was, similar to that of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, granulocyte-macrophage colony-stimulating factor (GM-CSF), and G-CSF, inhibited by IL-4. Furthermore we demonstrate here that IL-10, added to monocytes, activated by interferon gamma (IFN-gamma), LPS, or combinations of LPS and IFN-gamma at the onset of the cultures, strongly inhibited the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, GM-CSF, and G-CSF at the transcriptional level. Viral-IL-10, which has similar biological activities on human cells, also inhibited the production of TNF alpha and GM-CSF by monocytes following LPS activation. Activation of monocytes by LPS in the presence of neutralizing anti-IL-10 monoclonal antibodies resulted in the production of higher amounts of cytokines relative to LPS treatment alone, indicating that endogenously produced IL-10 inhibited the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, GM-CSF, and G-CSF. In addition, IL-10 had autoregulatory effects since it strongly inhibited IL-10 mRNA synthesis in LPS activated monocytes. Furthermore, endogenously produced IL-10 was found to be responsible for the reduction in class II major histocompatibility complex (MHC) expression following activation of monocytes with LPS. Taken together our results indicate that IL-10 has important regulatory effects on immunological and inflammatory responses because of its capacity to downregulate class II MHC expression and to inhibit the production of proinflammatory cytokines by monocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-10 inhibits production of pro-inflammatory cytokines, such as TNF127.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512 · cited 1×
“6% formaldehyde, transferred to Nytran nylon membranes (Schleicher & Schuell, Keene, NH) and hybridized with probes, labeled to high specific activity (>10 s cpm//~g) by the hexamer labeling technique (23).”
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460 · cited 1×
“Total ILNA was isolated from 20 x 106 monocytes by the guanidinium thioeyanateCsC1 procedure (22).”
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.bloodjournal7411 · Cited by 2,068
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975 · cited 1×
“the activation and function of cells of the immune system but also those of endothelial cells, keratinocytes and hepatocytes (42-44), suggests that II.”
Malefyt, R. D. W., Haanen, J. B. A. G., Spits, H., Roncarolo, M., Velde, A. A. T., Figdor, C. G., Johnson, K., KASTELEIN, R. A., Yssel, H., & de Vries, J. E. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Self-citationIL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,866
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,732 · cited 2×
“-6 sense primer 5'-ATGAACTCCTTCTCCACAAGC-3' (nt 1 - 21), Ib6 anti sense primer 5'-CTACATTTGCCGAAGAGCCCTCAGGCTGGACTG-3' (nt 810 - 777) (17), Ib8 sense primer 5'-ATGACTTCCAAGCTGGCCGTG-3' (nt 1 - 21), I1-8 anti sense primer 5'-TTATGAATTCTCAGCCCTCTTCAAAAACTTCTC-Y (nt 302 - 269) (15), IL-10 sense primer 5'-ATGCCCCAAGCTGAGA…”
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V. L., Gillis, S. A., Henney, C. S., Kronheim, S. R., Grabstein, K. H., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,559 · cited 2×
“The following oligonucleotides were used for Southern analysis of PCR products: IL-lot: 5'-CATGGGTGCTTATAAGTCATC-Y (nt 500-521) (16); IL-1/3: 5'-CGATCACTGAACTGCACGCTCCGGG-3' (nt 444 469) (16); Ib6: 5'GAGGTATACCTAGAGTACCTC-Y (nt 510 - 531) (17); IL-8: 5'-TAAAGACATACTCCAAACCTT-3' (nt 200 - 221) (15); IL-10: 5'-CAGGTGAAG…”
Cited by
Sorted by citations
Items 801–900 of 1,009
Brown, C. Y., Lagnado, C. A., Vadas, M. A., & Goodall, G. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.20108 · Cited by 94
Seifart, C., Dempfle, A., Plagens, A., Seifart, U., Clostermann, U., Müller, B., Vogelmeier, C. F., & von Wichert, P. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00343.x · Cited by 96
Ghigo, É., Capo, C., Raoult, D., & Mège, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2345-2352.2001 · Cited by 97
Portielje, J. E. A., Lamers, C. H. J., Kruit, W. H. J., Sparreboom, A., Bolhuis, R. L. H., Stoter, G., Huber, C., & Gratama, J. W. (2003) · PubMed · Cited by 97
Zdanov, A. S., Schalk‐Hihi, C., & Wlodawer, A. (1996) · Protein Science · doi:10.1002/pro.5560051001 · Cited by 97
Pelletier, R. P., Pravica, V., Perrey, C., Xia, D., Ferguson, R. M., Hutchinson, I. V., & Orosz, C. G. (2000) · Transplantation · doi:10.1097/00007890-200008270-00023 · Cited by 96
Serum Interleukin-10 in Human Acute Pancreatitis
Pezzilli, R., Billi, P., Miniero, R., & Barakat, B. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018814710291 · Cited by 97
Takami, T., Oudega, M., Bethea, J. R., Wood, P. M., Kleitman, N., & Bunge, M. B. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754118 · Cited by 96
Probst, P., Skeiky, Y. A. W., Steeves, M., Gervassi, A. L., Grabstein, K. H., & Reed, S. G. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271024 · Cited by 96
Vollmer-Conna, U. S., Piraino, B., Cameron, B., Davenport, T. A., Hickie, I. B., Wakefield, D., Lloyd, A. R., & Dubbo Infection Outcomes Study Group (2008) · Clinical Infectious Diseases · doi:10.1086/592967 · Cited by 94
Sugimoto, M., Furuta, T., Shirai, N., Nakamura, A., Kajimura, M., Sugimura, H., & Hishida, A. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04613.x · Cited by 96
Soares, M. B. P., Titus, R. G., Shoemaker, C. B., David, J. R., & Bozza, M. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1811 · Cited by 119
IL-10 Is a Central Regulator of Cyclooxygenase-2 Expression and Prostaglandin Production
Berg, D., Zhang, J., Lauricella, D. M., & Moore, S. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2674 · Cited by 95
T cells of the human intestinal lamina propria are high producers of interleukin-10
Braunstein, J., Qiao, L., Autschbach, F., Schürmann, G., & Meuer, S. C. (1997) · Gut · doi:10.1136/gut.41.2.215 · Cited by 96
Kim, J. J., Simbiri, K. A., Sin, J., Dang, K., Oh, J., Dentchev, T., Lee, D. C., Nottingham, L. K., Chalian, A. A., McCallus, D. E., et al. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099314441 · Cited by 96
Lü, N., Wang, L., Cao, H., Liu, L., Kaer, L. V., Washington, M. K., Rosen, M. J., Dubé, P. E., Wilson, K. T., Ren, X., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300133 · Cited by 95
“Because IL-10 has been shown to inhibit proinflammatory cytokine production in macrophages (11, 12), we examined whether the persistent increase in IL-10 production played a role in the development of and recovery from colitis in EgfrLysM-Cre mice.”
BackgroundSassi, A., Louzir, H., Salah, A. B., Mokni, M., Osman, A. B., & Dellagi, K. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00844.x · Cited by 95
Effects of Hepatitis C virus on cardiovascular risk in infected patients: A comparative study
de Oliveira, C. P. M. S., Kappel, C., de Siqueira, É. R. F., Lima, V., Stefano, J. T., Michalczuk, M. T., Marini, S. S., Barbeiro, H. V., Soriano, F. G., Carrilho, F. J., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.016 · Cited by 95
“inflammatory Th2 cytokine that down-regulates the expression of major histocompatibility complex (MHC) class I and class II molecules, as well as the production of Th1 cytokines [26–31].”
BackgroundChen, C.-Y., Tsen, H., Lin, C., Yu, B., & Chen, C.-S. (2012) · Poultry Science · doi:10.3382/ps.2012-02237 · Cited by 95
Musso, T., Deaglio, S., Franco, L., Calosso, L., Badolato, R., Garbarino, G. M., Dianzani, U., & Malavasi, F. (2001) · PubMed · Cited by 95
Scholzen, T. E., Sunderkötter, C. H., Kalden, D.-H., Brzoska, T., Fastrich, M., Fisbeck, T., Armstrong, C. A., Ansel, J. C., & Luger, T. A. (2002) · Endocrinology · doi:10.1210/en.2002-220651 · Cited by 95
Are differences in interleukin 10 production associated with joint damage?
Huizinga, T. W. J., Keijsers, V., Yanni, G., Hall, M., Ramage, W., Lanchbury, J. S. S., Pitzalis, C., Drossaers-Bakker, W., Westendorp, R. G. J., Breedveld, F. C., et al. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.11.1180 · Cited by 95
Interleukin-10 responses from acute exercise in healthy subjects: A systematic review
Cabral‐Santos, C., de Lima Junior, E. A., Fernandes, I. M. D. C., Pinto, R. Z., Rosa‐Neto, J. C., Bishop, N. C., & Lira, F. S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27920 · Cited by 96
Interleukin-10 and Tumor Necrosis Factor-α Gene Polymorphisms in Tuberculosis
Ates, Ö., Müsellim, B., Öngen, G., & Topal-Sarikaya, A. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9155-2 · Cited by 92
Alcocer-González, J. M., Berumen-Campos, J., Taméz-Guerra, R. S., Bermúdez-Morales, V. H., Peralta-Zaragoza, Ó., Hernández‐Pando, R., Moreno, J. G., Gariglio, P., & Madrid‐Marina, V. (2006) · Viral Immunology · doi:10.1089/vim.2006.19.481 · Cited by 91
Bracci‐Laudiero, L., Aloe, L., Caroleo, M. C., Buanne, P., Costa, N., Starace, G., & Lundeberg, T. (2005) · Blood · doi:10.1182/blood-2004-10-4055 · Cited by 93
Cytokine deregulation in cancer
Kurzrock, R. (2001) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00140-8 · Cited by 94
Xiu, B., Lin, Y., Grote, D. M., Ziesmer, S. C., Gustafson, M. P., Maas, M. L., Zhang, Z., Dietz, A. B., Porrata, L. F., Novak, A. J., et al. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.56 · Cited by 94
Musso, T., Deaglio, S., Franco, L., Calosso, L., Badolato, R., Garbarino, G. M., Dianzani, U., & Malavasi, F. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.605 · Cited by 94
Giannini, S. L., Al‐Saleh, W., Piron, H., Jacobs, N., Doyen, J., Boniver, J., & Delvenne, P. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00639.x · Cited by 94
Ho, W., Kaufman, D. A., Uvaydova, M., & Douglas, S. D. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00132-4 · Cited by 94
Braun, D. P., Gebel, H. M., House, R. V., Rana, N., & Dmowski, W. P. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58325-3 · Cited by 94
Regulation of IgE synthesis by cytokines
de Vries, J. E., Gauchat, J., Aversa, G., Punnonen, J., Gascan, H., & Yssel, H. (1991) · Current Opinion in Immunology · doi:10.1016/s0952-7915(05)80003-2 · Cited by 94
Shahi, A., Deirmengian, C. A., Higuera, C. A., Chen, A. F., Restrepo, C., Zmistowski, B. M., & Parvizi, J. (2015) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-015-4142-z · Cited by 93
Injectable Supramolecular Hydrogel/Microgel Composites for Therapeutic Delivery
Chen, M. H., Chung, J. J., Mealy, J. E., Zaman, S., Li, E. C., Arisi, M. F., Atluri, P., & Burdick, J. A. (2018) · Macromolecular Bioscience · doi:10.1002/mabi.201800248 · Cited by 93
Andolfi, G., Fousteri, G., Rossetti, M. M., Magnani, C. F., Jofra, T., Locafaro, G., Bondanza, A., Gregori, S., & Roncarolo, M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.71 · Cited by 93
Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging
Siglienti, I., Bendszus, M., Kleinschnitz, C., & Stoll, G. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.011 · Cited by 93
Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro
Cheng, P., Lee, Y., Wu, Y., Chang, T.-W., Jin, J., & Yen, M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.025 · Cited by 94
Xu, L. X., Kukita, T., Kukita, A., Otsuka, T., Niho, Y., & Iijima, T. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650321 · Cited by 93
Murthy, P. K., Dennis, V. A., Lasater, B. L., & Philipp, M. T. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6663-6669.2000 · Cited by 91
Schneider, C. P., Schwacha, M. G., & Chaudry, I. H. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.01.003 · Cited by 93
Merlo, A. C., Tenca, C., Fais, F., Battini, L., Ciccone, E., Grossi, C. E., & Saverino, D. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.6.705-712.2005 · Cited by 93
Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes.
Iannone, F., Bari, C. D., Dell’Accio, F., Covelli, M., Cantatore, F. P., Patella, V., Bianco, G., & Lapadula, G. (2001) · PubMed · Cited by 93
Arnold, R., Seifert, M., Asadullah, K., & Volk, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7140 · Cited by 93
Kim, J. J., Yang, J.-S., Manson, K. H., & Weiner, D. B. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00479-5 · Cited by 93
Interleukin-10 Modulates the Severity of Hypersensitivity Pneumonitis in Mice
Guðmundsson, G., Bosch, A., Davidson, B. L., Berg, D., & Hunninghake, G. W. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.5.3153 · Cited by 93
Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβ
Cavaillon, J., Pitton, C. N., & Fitting, C. (1994) · Journal of Endotoxin Research · doi:10.1177/096805199400100105 · Cited by 92
Adaptive immune cells in calcific aortic valve disease
Raddatz, M. A., Madhur, M. S., & Merryman, W. D. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00100.2019 · Cited by 97
Disulfide bond assignments and secondary structure analysis of human and murine interleukin 10
Windsor, W. T., Syto, R., Tsarbopoulos, A., Zhang, R., Durkin, J., Baldwin, S., Paliwal, S., Mui, P. W., & Pramanik, B. (1993) · Biochemistry · doi:10.1021/bi00085a011 · Cited by 92
Roatt, B. M., Aguiar‐Soares, R. D. D. O., Coura‐Vital, W., Ker, H. G., Moreira, N. D. D., Vitoriano-Souza, J., Giunchetti, R. C., Carneiro, C. M., & Reis, A. B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00272 · Cited by 92
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
Fife, M. S., del Arroyo, A. G., Ogilvie, E. M., Stock, C. J. W., Samuel, J., Thomson, W., Mack, L. F., Lewis, C. M., & Woo, P. M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2041 · Cited by 92
Current status and challenges of cytokine pharmacology
Zı́dek, Z., Anzenbacher, P., & Kmonı́čková, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00206.x · Cited by 96
Interaction ofMycobacterium tuberculosis-Induced Transforming Growth Factor β1 and Interleukin-10
Othieno, C., Hirsch, C. S., Hamilton, B. D., Wilkinson, K. A., Ellner, J. J., & Toossi, Z. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5730-5735.1999 · Cited by 92
Mueller, A. R., Platz, K., Haak, M., Undi, H., Müller, C. A., Kottgen, E., Weidemann, H., & Neuhaus, P. (1996) · Transplantation · doi:10.1097/00007890-199610270-00017 · Cited by 91
Interleukin-10 in Non-Hodgkin's Lymphoma
Cortes, J. E., & Kurzrock, R. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709051774 · Cited by 92
Involvement of interleukin-4 and -10 in inflammatory bowel disease
Nielsen, O. H., Koppen, T., Rüdiger, N., Horn, T. D., Eriksen, J., & Kirman, I. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02088746 · Cited by 91
Mahanty, S., Ravichandran, M., Raman, U., Jayaraman, K., Kumaraswami, V., & Nutman, T. B. (1997) · Infection and Immunity · doi:10.1128/iai.65.5.1742-1747.1997 · Cited by 92
Ouyang, P., Rakus, K. Ł., van Beurden, S. J., Westphal, A. H., Davison, A. J., Gatherer, D., & Vanderplasschen, A. F. C. (2013) · Journal of General Virology · doi:10.1099/vir.0.058966-0 · Cited by 88
“This resulted in a decrease of antigen presentation by monocytes and, as a consequence, a reduction of T-cell proliferation (de Waal Malefyt et al., 1991b).”
BackgroundInfluentialNguyen, H. D., Aljamaei, H. M., & Stadnyk, A. W. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.005 · Cited by 96
Knolle, P. A., Uhrig, A., Protzer, U., Trippler, M., Duchmann, R., Büschenfelde, K. M. Z., & Gerken, G. (1998) · Hepatology · doi:10.1002/hep.510270116 · Cited by 91
The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases
Weiss, E., Mamelak, A. J., Morgia, S. L., Wang, B., Feliciani, C., Tulli, A., & Sauder, D. N. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.11.075 · Cited by 91
TNF‐α, TNF‐β, IL‐6, and IL‐10 Polymorphisms in Patients with Lung Cancer
Seifart, C., Plagens, A., Dempfle, A., Clostermann, U., Vogelmeier, C. F., von Wichert, P., & Seifart, U. (2005) · Disease Markers · doi:10.1155/2005/707131 · Cited by 91
In vivo effects of interleukin-10 on human cytochrome P450 activity
Gorski, J. C. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.103860 · Cited by 91
Pulmonary Cytokine and Chemokine mRNA Levels after Inhalation of Lipopolysaccharide in C57BL/6 Mice
Johnston, C. J., Finkelstein, J. N., Gelein, R. M., & Oberdörster, G. (1998) · Toxicological Sciences · doi:10.1006/toxs.1998.2557 · Cited by 91
IL-10 PRODUCTION BY ADULT HUMAN DERIVED MICROGLIAL CELLS
Williams, K. C., Dooley, N. P., Ulvestad, E., Becher, B., & Antel, J. P. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00138-7 · Cited by 91
Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
Whittington, R. A., Planel, E., & Terrando, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01464 · Cited by 93
Thaunat, O., Beaumont, C., Chatenoud, L., Lechaton, S., Mamzer, M., Varet, B. R., Kreis, H., & Morélon, E. (2005) · Transplantation · doi:10.1097/01.tp.0000179106.07382.6a · Cited by 89
Human IL‐19 regulates immunity through auto‐induction of IL‐19 and production of IL‐10
Jordan, W. J., Eskdale, J., Boniotto, M., Lennon, G. P., Peat, J. E., Campbell, J. D. M., & Gallagher, G. E. (2005) · European Journal of Immunology · doi:10.1002/eji.200425317 · Cited by 91
Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?
Mühl, H. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00018 · Cited by 92
“Specifically, production of prototypic pro-inflammatory cytokines such as IL-1, tumor necrosis factor (TNF)-α, and IL-12 is potently inhibited by IL-10 in the aforementioned cell types (de Waal Malefyt et al., 1991; Fiorentino et al., 1991; Isler et al., 1999; Corinti et al., 2001).”
BackgroundInterleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis
Oral, H. B., Budak, F., Uzaslan, E. K., Baştürk, B., Bekâr, A., Akalın, H., Eğe, E., Ener, B., & Göral, G. (2006) · Cytokine · doi:10.1016/j.cyto.2006.07.015 · Cited by 90
Kim, K. N., Watanabe, S., Ma, Y., Thornton, S., Giannini, E. H., & Hirsch, R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1576 · Cited by 90
Chemokine production by human vascular smooth muscle cells: modulation by IL‐13
Jordan, N., Watson, M., Williams, R. J., Roach, A. G., Yoshimura, T., & Westwick, J. K. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701433 · Cited by 90
Borish, L., Schmaling, K. B., Diclementi, J. D., Streib, J. E., Negri, J. A., & Jones, J. F. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70090-9 · Cited by 90
Aman, M., Rudolf, G., Goldschmitt, J., Aulitzky, W. E., Lam, C., Huber, C. G., & Peschel, C. (1993) · Blood · doi:10.1182/blood.v82.8.2371.2371 · Cited by 90
Qin, L., Ding, Y., Pahud, D. R., Robson, N. D., Shaked, A. A., & Bromberg, J. S. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.11-1365 · Cited by 90
T-Cell Cytokines in Injury-Induced Neural Damage and Repair
Schroeter, M., & Jander, S. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:3:183 · Cited by 89
Nadigel, J., Préfontaine, D., Baglole, C. J., Maltais, F., Bourbeau, J., Eidelman, D. H., & Hamid, Q. A. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-149 · Cited by 93
Retini, C., Vecchiarelli, A., Monari, C., Bistoni, F., & Kozel, T. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.2.664-669.1998 · Cited by 89
Uccioli, L., Sinistro, A., Almerighi, C., Ciaprini, C., Cavazza, A., Giurato, L., Ruotolo, V., Spasaro, F., Vainieri, E., Rocchi, G., et al. (2009) · Diabetes Care · doi:10.2337/dc09-1141 · Cited by 89
Interleukin-10 and the Monocyte/Macrophage-Induced Inflammatory Response in Septic Shock
Gomez-Jimenez, J., Martín, M., Saurí, R., Segura, R., Esteban, F., Ruiz, J. C., Nuvials, X., Jl, B., Peracaula, R., & Salgado, A. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.472 · Cited by 88
Differential Regulation of Interleukin (IL)–4, IL‐5, and IL‐10 during Measles in Zambian Children
Moss, W. J., Ryon, J. J., Monze, M., & Griffin, D. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/344230 · Cited by 89
Mycobacterium bovis Bacillus Calmette Guérin infection prevents apoptosis of resting human monocytes
Kremer, L., Estaquier, J., Brandt, E. B., Ameisen, J., & Locht, C. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270945 · Cited by 89
Endogenous mediators that inhibit the leukocyte– endothelium interaction
Perretti, M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01116-4 · Cited by 89
Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy.
Libraty, D. H., Airan, L. E., Uyemura, K., Jullien, D., Spellberg, B. J., Rea, T. H., & Modlin, R. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119162 · Cited by 89
Silva, M. L., Martins, M. Â., Santo, L. R. E., Campi‐Azevedo, A. C., Silveira-Lemos, D., Ribeiro, J. G. L., Homma, A., Kroon, E. G., Teixeira‐Carvalho, A., Elói-Santos, S. M., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.046 · Cited by 88
Effects of Microglial Activation and Polarization on Brain Injury After Stroke
Dong, R., Huang, R., Wang, J., Liu, H., & Xu, Z. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.620948 · Cited by 87
Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice
Mesplès, B., Plaisant, F., & Gressèns, P. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00636-3 · Cited by 88
Bozkurt, F., Yetkin-Ay, Z., Berker, E., Tepe, E. R., & Akkuş, S. (2006) · Cytokine · doi:10.1016/j.cyto.2006.07.020 · Cited by 88
Endogenous Interleukin-10 Modulates Proinflammatory Response in Plasmodium falciparum Malaria
Ho, M., Schollaardt, T., Snape, S., Looareesuwan, S., Suntharasamai, P., & White, N. J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515640 · Cited by 88
Clinical, hematologic, and immunologic effects of interleukin-10 in humans
Fuchs, A. C., Granowitz, E. V., Shapiro, L., Vannier, E. G., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Radwanski, E., Affrime, M. B., et al. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01541395 · Cited by 88
Interleukin-10 as a Regulatory Cytokine Induced by Cellular Stress: Molecular Aspects
Stordeur, P., & Goldman, M. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043006 · Cited by 87
Balcewicz-Sablinska, M. K., Gan, H., & Remold, H. G. (1999) · The Journal of Infectious Diseases · doi:10.1086/315011 · Cited by 88
Immune responses of cattle to African trypanosomes: protective or pathogenic?
Taylor, K. (1998) · International Journal for Parasitology · doi:10.1016/s0020-7519(97)00154-9 · Cited by 121
Traumatic inflammatory response: pathophysiological role and clinical value of cytokines
Li, R., Ye, J. J., Gan, L., Zhang, M., Sun, D., Li, Y., Wang, T., & Chang, P. (2023) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-023-02388-5 · Cited by 87
“It can inhibit pro-inflammatory cytokines, including TNF-α, IL-1, IL-6, and IFN-γ [88], and reduce the synthesis of major histocompatibility complex II (MHCII), as well as adhesion and co-stimulatory molecules, thereby limiting effector T-cell responses [89].”
BackgroundKurte, M., López, M. N., Aguirre, A., Escobar, A. F., Aguillón, J. C., Charo, J., Larsen, C. G., Kiessling, R. W., & Salazar‐Onfray, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1731 · Cited by 85
Dickensheets, H. L., Freeman, S. L., Smith, M. F., & Donnelly, R. P. (1997) · Blood · doi:10.1182/blood.v90.10.4162 · Cited by 87
Suabjakyong, P., Nishimura, K., Toida, T., & Griensven, L. J. L. D. V. (2015) · Food & Function · doi:10.1039/c5fo00491h · Cited by 88
Jung, M., Sabat, R., Krätzschmar, J., Seidel, H., Wolk, K., Schönbein, C., Schütt, S., Friedrich, M., Döcke, W., Asadullah, K., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324323 · Cited by 87
Pender, S. L. F., Breese, E. J., Günther, U., Howie, D., Wathen, N. C., Schuppan, D., & MacDonald, T. T. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70136-2 · Cited by 87
Solomon, B., Desai, J., Rosenthal, M. A., McArthur, G. A., Pattison, S. T., Pattison, S. L., MacDiarmid, J. A., Brahmbhatt, H. N., & Scott, A. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144559 · Cited by 87
“In this study, patients showed a transient elevation in TNFα and IL-6 within 4h post-dose which was associated with occasional rigors, although a simultaneous spike in IL-10 which is known to suppress the pyrogenicity of IL-6 [13, 14] was also observed.”
BackgroundInfluential
Metadata
- Authors
- de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E.
- Affiliations
- Department of Human Immunology, DNAX Research Institute, Palo Alto, California 94304.
- ORCID
- Figdor, C G
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1991-11-01
- Volume
- 174
- Issue
- 5
- Pages
- 1209-1220
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2119001
- OpenAlex
- W2191654227
- Cited by
- 3,762
- References
- 41
- Citations by year
- 2026: 25 · 2025: 41 · 2024: 45 · 2023: 60 · 2022: 58 · 2021: 68 · 2020: 67 · 2019: 80 · 2018: 69 · 2017: 71 · 2016: 97 · 2015: 98 · 2014: 132 · 2013: 107 · 2012: 122
- FWCI
- 39.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- IL-10, monocytes, cytokine synthesis inhibition, lipopolysaccharide stimulation, interferon-gamma, autoregulation, cytokine gene expression, MHC class II expression, viral IL-10, TNF-α, GM-CSF, granulocyte colony-stimulating factor, interleukin-6, interleukin-8
- MeSH terms
- Histocompatibility Antigens Class II, Base Sequence, Cells, Cultured, Homeostasis, Humans, Interferon-gamma, Interleukin-1, Lipopolysaccharides, Molecular Sequence Data, Monocytes, RNA, Messenger, Transcription, Genetic, Interleukin-4, Interleukin-6, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Transforming Growth Factor beta, Interleukin-10
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review